Tuspetinib
HM-FLTI-101
Phase 2 small_molecule active
Quick answer
Tuspetinib for Leukemia, Myeloid, Acute is a Phase 2 program (small_molecule) at Aptose Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aptose Biosciences
- Indication
- Leukemia, Myeloid, Acute
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active